Finnish Health Agency, Fimea, has reported that it discovered falsified copies of Janssen-Cilag’s cancer treatment Velcade in hospital pharmacies. The falsified batches of Velcade (bortezomib 3.5mg powder for injection) packs were imported into the country by parallel distributor Orifarm Oy. Nine packs of the suspect treatment were used to treat patients before the falsification was identified, according to Fimea.
This discovery comes after a string of incidents involving suspected counterfeit Velcade in Germany, the Netherlands and Denmark. All reported cases appear to be linked to repackaging by parallel importers: the batches seemed to contain the right active ingredient at the right level, but with falsified packaging.
Source : www.securingindustry.com